WELL Health Technologies Corp (WELL), the Technology company, was revisited by a Wall Street analyst today. The Technology company, WELL Health Technologies Corp (TSXV: WELL) has just received a rating update from a Wall Street analyst.
According to TipRanks.com, Keywood is a 2-star analyst with an average return of -0.3% and a 40.0% success rate. Keywood covers the Healthcare sector, focusing on stocks such as Cipher Pharmaceuticals, Knight Therapeutics, and Aphria Inc.
Read also: Can Baidu (BIDU) Stock Keep Going After This Week’s Pop?
Currently, the analyst consensus on WELL Health Technologies Corp is a Moderate Buy with an average price target of C$1.65.
Based on WELL Health Technologies Corp’s latest earnings release for the quarter ending March 31, the company reported a quarterly GAAP net loss of C$1.45 million. In comparison, last year the company had a GAAP net loss of C$702.7K.
WELL Health Technologies Corp. owns and operates a portfolio of primary healthcare facilities. It operates through Shakti and CYI segments. The Shakti segment focuses on the sale of yoga clothing. The CYI segment involves in the operation of yoga studio. The company was founded by Hamed Shahbazi on November 23, 2010 and is headquartered in Vancouver, Canada.
The company’s shares closed last Thursday at C$1.73, close to its 52-week high of C$1.87.
